Richard Adcock Immunity Bio, Inc. (IBRX) insider trading activity

Richard Adcock is CEO & President of ImmunityBio, Inc.. Currently has a direct ownership of 351,391 shares of IBRX, which is worth approximately $730,893. The most recent transaction as insider was on Dec 31, 2025, when has been sold 17,510 shares (Common Stock) at a price of $1.98 per share, resulting in proceeds of $34,669. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 351K

5.08% 3M change

35.07% 12M change

Total Value Held $730,893

Richard Adcock Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 31 2025	SELL Payment of exercise price or tax liability	$34,669 $1.98 p/Share	17,510 Reduced 4.75%	351,391 Common Stock
Dec 31 2025	BUY Exercise of conversion of derivative security	-	34,483 Added 8.55%	368,901 Common Stock
Feb 22 2025	SELL Payment of exercise price or tax liability	$267,331 $3.42 p/Share	78,167 Reduced 18.95%	334,418 Common Stock
Feb 22 2025	BUY Exercise of conversion of derivative security	-	152,439 Added 26.98%	412,585 Common Stock
Dec 31 2024	SELL Payment of exercise price or tax liability	$44,736 $2.56 p/Share	17,475 Reduced 6.29%	260,146 Common Stock
Dec 31 2024	BUY Exercise of conversion of derivative security	-	34,483 Added 11.05%	277,621 Common Stock
Feb 05 2024	SELL Payment of exercise price or tax liability	$174,386 $4.04 p/Share	43,165 Reduced 15.08%	243,138 Common Stock

Feb 05 2024	BUY Exercise of conversion of derivative security	-	83,334 Added 22.54%	286,303 Common Stock
Dec 31 2023	SELL Payment of exercise price or tax liability	$85,821 $5.02 p/Share	17,096 Reduced 7.77%	202,969 Common Stock
Dec 31 2023	BUY Exercise of conversion of derivative security	-	34,483 Added 13.55%	220,065 Common Stock
Feb 05 2023	SELL Payment of exercise price or tax liability	$182,691 $4.33 p/Share	42,192 Reduced 18.52%	185,582 Common Stock
Feb 05 2023	BUY Exercise of conversion of derivative security	-	83,333 Added 26.79%	227,774 Common Stock
Dec 31 2022	SELL Payment of exercise price or tax liability	$21,664 $5.07 p/Share	4,273 Reduced 2.87%	144,441 Common Stock
Dec 31 2022	BUY Exercise of conversion of derivative security	-	8,620 Added 5.48%	148,714 Common Stock
Feb 05 2022	SELL Payment of exercise price or tax liability	$158,547 $5.39 p/Share	29,415 Reduced 17.35%	140,094 Common Stock
Feb 05 2022	BUY Exercise of conversion of derivative security	-	83,333 Added 32.96%	169,509 Common Stock
Sep 09 2021	SELL Payment of exercise price or tax liability	$42,516 $9.95 p/Share	4,273 Reduced 4.72%	86,176 Common Stock
Sep 09 2021	BUY Exercise of conversion of derivative security	-	8,620 Added 8.7%	90,449 Common Stock
Feb 05 2021	SELL Payment of exercise price or tax liability	$1,617,016 $23.72 p/Share	68,171 Reduced 45.45%	81,829 Common Stock
Feb 05 2021	BUY Exercise of conversion of derivative security	-	150,000 Added 50.0%	150,000 Common Stock

Richard Adcock

CEO & President

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IBRX shares.

Notify only if

Value

Insider Trading

Get notified when an Immunity Bio, Inc. insider buys or sells IBRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to ImmunityBio, Inc.

Track Activities on IBRX

Account